Guardian Pharmacy Services, Inc. (GRDN): who owns it and who trades it
As of Nov 16, 2026, GRDN insiders reported 6 open-market sales worth $175M and 1 purchase worth $99.8K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Thomas J Salentine Jr (Director), with $106M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Guardian Pharmacy Services
From the latest filingsOverall: more selling than buying. Insiders and famous investors mostly sold. Funds mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns GRDN
189 funds and institutions reported GRDN shares worth $1.2B at the end of Q2 2026. The largest holder is FMR LLC (Fidelity) with $136M.
10 largest owners, by value
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| FMR LLC (Fidelity) | 3.24M | – | $136M | +37% |
| Wellington Management Group LLP | 1.73M | – | $72.4M | -2% |
| BlackRock, Inc. | 1.58M | – | $66M | -10% |
| California State Teachers Retirement System | 1.42M | – | $33.8M | +7849% |
| Vanguard Capital Management LLC | 1.38M | – | $57.8M | +13% |
| Woodline Partners LP | 1.31M | – | $54.7M | No change |
| Valiant Capital Management, L.P. | 1.19M | – | $49.7M | No change |
| T. Rowe Price Investment Management, Inc. | 1.12M | – | $46.8M | +9% |
| Boston Partners | 983,868 | – | $40.8M | -3% |
| Franklin Resources Inc | 966,206 | – | $40.5M | +1% |
| Loomis Sayles & Co L P | 869,836 | – | $36.4M | -7% |
| Boone Capital Management LLC | 711,939 | – | $29.8M | +13% |
| Geode Capital Management, LLC | 646,695 | – | $27.1M | +16% |
| Jennison Associates LLC | 626,664 | – | $26.2M | -24% |
| State Street Corp | 590,114 | – | $24.7M | +16% |
| Bessemer Group Inc | 548,029 | – | $22.9M | +597% |
| Brown Advisory Inc | 524,013 | – | $21.9M | -58% |
| Dimensional Fund Advisors LP | 516,094 | – | $21.6M | +147% |
| Driehaus Capital Management LLC | 510,161 | – | $21.4M | -13% |
| First Trust Advisors LP | 461,307 | – | $19.3M | +392% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, GRDN insiders reported $99.8K of open-market purchases and $175M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Pharmacy Investors, LLC | Other | Sale | 827,636 | $29.68 | $24.6M | Form 4 |
| Mar 20, 2026 | Fred Burke | Director | Sale | 671,432 | $29.68 | $19.9M | Form 4 |
| Mar 20, 2026 | David K Morris | Director | Sale | 187,855 | $29.68 | $5.6M | Form 4 |
| Mar 20, 2026 | Thomas J Salentine Jr | Director | Sale | 3.57M | $29.68 | $106M | Form 4 |
| Mar 20, 2026 | John Ackerman | Director | Sale | 275,728 | $29.68 | $8.2M | Form 4 |
| Mar 20, 2026 | Kendall Forbes | See Remarks | Sale | 346,672 | $29.68 | $10.3M | Form 4 |
| Dec 3, 2025 | Steven D Cosler | Director | Purchase | 3,370 | $29.61 | $99.8K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Thomas J Salentine Jr | Director, 10% owner | – | $106M | Mar 20, 2026 |
| Pharmacy Investors, LLC | Other | – | $24.6M | Mar 20, 2026 |
| Fred Burke | See Remarks, Director | – | $19.9M | Mar 20, 2026 |
| Kendall Forbes | See Remarks | – | $10.3M | Mar 20, 2026 |
| John Ackerman | Director | – | $8.2M | Mar 20, 2026 |
| David K Morris | See Remarks, Director | – | $5.6M | Mar 20, 2026 |
| Steven D Cosler | Director | $99.8K | – | Dec 3, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
GRDN short interest
2.20M GRDN shares are sold short. Over the last 12 reports the number of shares short went down 20%.
As of Oct 30, 2026, 2.20M GRDN shares were sold short, down 7.5% from the report before. At the average daily volume of 332,004 shares, buying them all back would take about 6.6 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 2.20M | – | -8% | 332,004 | 6.6 |
| Oct 15, 2026 | 2.38M | – | -4% | 448,487 | 5.3 |
| Sep 30, 2026 | 2.48M | – | +2% | 810,875 | 3.1 |
| Sep 15, 2026 | 2.43M | – | -20% | 651,725 | 3.7 |
| Aug 31, 2026 | 3.04M | – | +1% | 323,308 | 9.4 |
| Aug 14, 2026 | 3.01M | – | +5% | 406,699 | 7.4 |
| Jul 31, 2026 | 2.85M | – | +2% | 298,765 | 9.6 |
| Jul 15, 2026 | 2.79M | – | -10% | 391,398 | 7.1 |
| Jun 30, 2026 | 3.09M | – | -5% | 588,424 | 5.2 |
| Jun 15, 2026 | 3.24M | – | +11% | 374,122 | 8.7 |
| May 29, 2026 | 2.91M | – | +5% | 395,636 | 7.4 |
| May 15, 2026 | 2.77M | – | +3% | 440,561 | 6.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Guardian Pharmacy Services company events
Guardian Pharmacy Services filed 10 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Sep 10, 2026AnnouncementGuardian Pharmacy Services, Inc. entered into lock-up agreements with its founders, executive officers and certain other employees who hold shares of the Company’s Class A common stock. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jun 22, 2026LeadershipGuardian Pharmacy Services, Inc. announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since the Company was founded in 2004, will retire from all positions with the Company effective July 1, 2026. Filing
- May 28, 2026AgreementGuardian Pharmacy Services, Inc., as borrower, and certain of its subsidiaries, as guarantors, entered into the Eighth Amendment to the Third Amended and Restated Loan and Security Agreement dated as of April 23, 2018 (as amended from time to time, the “Loan Agreement”), with the lenders party… Filing
- May 7, 2026VoteReported shareholder vote results. Filing
- May 6, 2026ResultsReleased financial results. Filing
- Mar 23, 2026AgreementGuardian Pharmacy Services, Inc. entered into stock purchase agreements (each, a “Stock Purchase Agreement” and collectively, the “Stock Purchase Agreements”) with certain holders of shares of the Company’s Class A common stock that were issued upon conversion of shares of the Company’s Class B… Filing
- Mar 11, 2026ResultsReleased financial results. Filing
- Jan 13, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Guardian Pharmacy Services financials
Famous investors that hold GRDN
2 of the 50 well-known investors we track reported holding GRDN in their latest 13F filing. The largest position is Jim Simons's, worth $1.5M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 37,428 | $1.5M | 0.0% | -16% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 34,740 | $1.4M | 0.0% | -60% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named GRDN in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 5, 2026 | FMR LLC | 13G/A | 5.0% |
| Nov 5, 2026 | FMR LLC | 13G/A | 5.0% |
Questions about Guardian Pharmacy Services, Inc. (GRDN) stock
Who owns the most GRDN stock?
The largest reported owner of Guardian Pharmacy Services, Inc. (GRDN) is FMR LLC (Fidelity). In total, 189 funds and institutions reported holding GRDN at the end of Q2 2026. See the largest owners.
Are GRDN insiders buying or selling?
In the last 12 months, GRDN insiders reported 1 open-market purchase worth $99.8K and 6 sales worth $175M. The latest trade was on Mar 20, 2026. See every trade.
What is the short interest in GRDN?
As of Oct 30, 2026, 2.20M GRDN shares were sold short, down 7.5% from the report before. At the average daily volume of 332,004 shares, buying them all back would take about 6.6 trading days (days to cover). See the history.
Which famous investors hold GRDN?
2 of the 50 well-known investors we track reported GRDN in their latest 13F filing, including Jim Simons, Ken Griffin. The largest position is worth $1.5M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.